FDA product code · Cardiovascular
Embolization Agent, Vascular
2 FDA decisions since 2023. No recall names this code.
For occluding peripheral vessels
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly Download the data (CSV)
Twenty years of QVG at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.
FDA decisions per year · QVG
9so far in 2026, the most since 2007
2026 to Oct 25, outlined.
Median 510(k) review, days · QVG
Too few QVG 510(k)s in any year since 2007 to give a median.
Recalls per year · QVG
No recall names QVG since 2007.
Adverse event reports per year · QVG
16in 2025
MAUDE reports naming product code QVG, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 3 | — | 0 | 0 |
| 2024 | 1 | — | 0 | 2 |
| 2025 | 7 | — | 0 | 16 |
| 2026 | 9 | — | 0 | — |
Planning a device in QVG? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report